Filter
747
Filtered Results: 747
Text search:
Condiciones
genéticas
Featured
Recommendations
52
New Publications
142
Language
Document type
No document type
369
Studies & Reports
153
Guidelines
123
Manuals
58
Strategic & Response Plan
22
Training Material
10
Fact sheets
9
Online Courses
2
Situation Updates
1
Countries / Regions
Global
41
India
39
Latin America and the Carribbean
19
South Africa
17
Kenya
15
Philippines
12
Africa
10
Western and Central Europe
9
Ethiopia
9
Uganda
8
Nigeria
7
Tanzania
7
Nepal
6
Ghana
6
Rwanda
6
Brazil
6
Namibia
6
Liberia
6
Ukraine
5
Asia
5
Venezuela
5
Congo, Democratic Republic of
5
Paraguay
5
Zambia
5
Sierra Leone
4
Peru
4
Malawi
4
West and Central Africa
4
East and Southern Africa
4
Argentina
4
Bangladesh
4
Ecuador
4
Myanmar / Burma
4
Colombia
3
Lesotho
3
Chile
3
Syria
3
Germany
3
Angola
3
Indonesia
3
Canada
2
Senegal
2
Afghanistan
2
Zimbabwe
2
Guinea
2
Mozambique
2
Haiti
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Eastern Europe
2
Russia
2
Mexico
1
Kazakhstan
1
Cameroon
1
Iran
1
Albania
1
Singapore
1
Burkina Faso
1
USA
1
Middle East and North Africa
1
Western Pacific Region
1
North America
1
Turkmenistan
1
France
1
Portugal
1
Latvia
1
Côte d’Ivoire / Ivory Coast
1
Sri Lanka
1
Central African Republic
1
Honduras
1
Mali
1
Chad
1
Botswana
1
Madagascar
1
Eswatini/ Swaziland
1
Pakistan
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
220
Clinical Guidelines
65
Public Health
61
Women & Child Health
26
Pharmacy & Technologies
25
Key Resources
16
Capacity Building
9
Toolboxes
Mental Health
111
COVID-19
43
Planetary Health
41
AMR
39
NTDs
37
TB
36
Pharmacy
33
NCDs
33
Rapid Response
26
HIV
23
Caregiver
18
Disability
16
Malaria
13
Global Health Education
13
Ebola & Marburg
11
Specific Hazards
8
Conflict
8
Zika
8
Polio
8
Refugee
5
Health Financing Toolbox
4
Cholera
3
Natural Hazards
2
Social Ethics
2
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, WHO has developed a system of indicators that measure important aspects of a country’s pharmaceutical situation. Level 1 indicators measure the existence and ...
SHOPS and HIA finalized a scope of work with USAID Senegal in April 2015, and a team of five private sector experts conducted the onsite assessments between May and June 2015. The Private Sector Assessment (PSA) team worked closely with Senegalese key stakeholders throughout the process. The PSA tea...
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo...
In this report, potential reasons for this apparent
contradiction between cherished human values
and observed social actions are explored with a
view to better formulating concrete steps that
governments and other stakeholders can take to
reshape social attitudes and public policy.
Guidelines
HIV testing services
July 2015
Why bold action against inequalities is needed to en AIDS, stop COVID-19 and prepare for future pandemics
During this work, a survey on essential medicines availability was conducted. This article was first written on this subject for sharing the poor financial availability of the essential medicines in the hospital and secondly, a call for an action to be taken in improving hospital pharmacies developm...
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
In order to meet changing global population needs and consumer expectations, healthcare systems worldwide are under transformation and face restructuring. As systems adapt and shift their emphasis in response to the disparate requests for healthcare services, oppor-tunities emerge for nurses, especi...
The Commission on Macroeconomics and Health (CMH) was established by World Health Organization Director-General Gro Harlem Brundtland in January 2000 to assess the place of health in global economic development. Although health is widely understood to be both a central goal and an important outcome ...
Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda
Antibiotics 2022, 11(3), 329; https://doi.org/10.3390/antibiotics11030329.
The authors found that the most-represented antibiotics on the Rwandan market were amoxicillin, co-trimoxazole and cloxacillin. No counterfeit antibiotics were found in this study. However, substandard batches with moderate ...
Module 10
Testing providers
July 2017
Module 10: Testing providers. This module is for people who provide testing services at PrEP sites and laboratories. It offers guidance in selecting testing services, including screening of individuals before PrEP is initiated and monitoring while they ar...
Since the discovery of insulin nearly 100 years ago, advances in diabetes treatments and therapies have transformed the lives of people
with diabetes (PwD), notably reducing the daily burden of its management.
Newer technologies, including those driven by artificial intelligence, have the potentia...
